Also trades as: 0HI3.L (LSE) · $vol 0M
ARWR NASDAQ
Arrowhead Pharmaceuticals, Inc.
1W: -5.3%
1M: +2.1%
3M: +18.7%
YTD: +11.4%
1Y: +363.5%
3Y: +100.6%
5Y: +3.7%
$74.95
-0.59 (-0.78%)
Weekly Expected Move ±7.6%
$65
$71
$77
$83
$88
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$622M
Revenue
+9.4% YoY
$-301M
Net Income
-109.0% YoY
$-51M
Free Cash Flow
-630.1% YoY
100.0%
Gross Margin
-191.6%
Op. Margin
-180.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-92.4%
ROA-23.8%
ROIC201.4%
Valuation
P/E-35.5
P/B17.4
EV/EBITDA-62.3
Leverage
Debt/Equity0.79
Current Ratio4.86
Interest Cov.-1.7x
Quality Scores
Piotroski F2/9
Altman Z5.15
Beneish M-5.98